Last updated: March 17, 2025
Sponsor: University of Miami
Overall Status: Completed
Phase
N/A
Condition
Transdermal Continuous Oxygen Therapy (Tcot)
Treatment
Nasal cannula flow rate
Clinical Study ID
NCT03431818
20170816
All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Premature infants born between 23 and 30 weeks of gestational age
Receiving supplemental oxygen via nasal cannula
Parental informed consent
Exclusion
Exclusion Criteria:
Major congenital anomalies
Clinically unstable
Study Design
Total Participants: 35
Treatment Group(s): 1
Primary Treatment: Nasal cannula flow rate
Phase:
Study Start date:
April 04, 2018
Estimated Completion Date:
September 07, 2023
Study Description
Connect with a study center
NICU at Holtz Children's Hospital
Miami, Florida 33136
United StatesSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.